Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1984 Apr;81(7):2152–2156. doi: 10.1073/pnas.81.7.2152

Differential effects of the mottled yellow and pseudoagouti phenotypes on immunocompetence in Avy/a mice.

D W Roberts, G L Wolff, W L Campbell
PMCID: PMC345455  PMID: 6609359

Abstract

Whereas genetic factors are known to influence both susceptibility to carcinogens and the capacity to respond to specific antigenic stimuli, little is known regarding the influence of phenotype per se. With this in mind, we utilized (YS x VY)F1 hybrid mice consisting of genetically identical (Avy/a) but phenotypically distinct (mottled yellow and pseudoagouti) mice as well as congeneic (a/a) black mice to evaluate immunocompetence as a function of genotype and phenotype. Mottled yellow Avy/a mice, which are fat and have increased susceptibility to neoplasia, presented an immunologic profile characterized by decreased antibody response to the T-cell-dependent immunogen tetanus toxoid, enhanced antibody response to the T-cell-independent immunogen type III pneumococcal polysaccharide, decreased (unadjusted) rates of carbon clearance, and increased levels of serum IgA. In contrast, pseudoagouti Avy/a mice were immunologically comparable to black a/a mice. The data demonstrate that differences in phenotypic expression between genetically identical mice may significantly alter immune function.

Full text

PDF
2152

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson G. L., Zembala M. Suppression of contact sensitivity by T cells in the mouse. I. Demonstration that suppressor cells act on the effector stage of contact sensitivity; and their induction following in vitro exposure to antigen. Proc R Soc Lond B Biol Sci. 1974 Nov 5;187(1088):329–348. doi: 10.1098/rspb.1974.0078. [DOI] [PubMed] [Google Scholar]
  2. Benson R. W., Roberts D. W. Evaluation of the immune response to type III pneumococcal polysaccharide as a means to evaluate T-independent immune function in the rat. J Toxicol Environ Health. 1982 Dec;10(6):859–870. doi: 10.1080/15287398209530301. [DOI] [PubMed] [Google Scholar]
  3. Blair P. B., Kripke M. L., Lappé M. A., Bonhag R. S., Young L. Immunologic deficiency associated with mammary tumor virus (MTV) infection in mice: hemagglutinin response and allograft survival. J Immunol. 1971 Feb;106(2):364–370. [PubMed] [Google Scholar]
  4. Bremberg S., Klein E., Stjernswärd J. Effect of heterologous antilymphoid-cell serum on tumor isografts and viral leukemogenesis. Cancer Res. 1967 Nov;27(11):2113–2118. [PubMed] [Google Scholar]
  5. Burnet F. M. The concept of immunological surveillance. Prog Exp Tumor Res. 1970;13:1–27. doi: 10.1159/000386035. [DOI] [PubMed] [Google Scholar]
  6. Chandra R. K. Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice. Am J Clin Nutr. 1980 Jan;33(1):13–16. doi: 10.1093/ajcn/33.1.13. [DOI] [PubMed] [Google Scholar]
  7. Chandra R. K. Cell-mediated immunity in nutritional imbalance. Fed Proc. 1980 Nov;39(13):3088–3092. [PubMed] [Google Scholar]
  8. Ellens D. J., Gielkens A. L. A simple method for the purification of 5-aminosalicylic acid. Application of the product as substrate in enzyme-linked immunosorbent assay (ELISA). J Immunol Methods. 1980;37(3-4):325–332. doi: 10.1016/0022-1759(80)90318-x. [DOI] [PubMed] [Google Scholar]
  9. Fernandes G., Friend P., Yunis E. J., Good R. A. Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1500–1504. doi: 10.1073/pnas.75.3.1500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fernandes G., West A., Good R. A. Nutrition, immunity, and cancer--a review. Part III: Effect of diet on the diseases of aging. Clin Bull. 1979;9(3):91–106. [PubMed] [Google Scholar]
  11. Galbraith D. B., Wolff G. L. Aberrant regulation of the Agouti pigment pattern in the viable yellow mouse. J Hered. 1974 May-Jun;65(3):137–140. doi: 10.1093/oxfordjournals.jhered.a108484. [DOI] [PubMed] [Google Scholar]
  12. Gasser D. L., Fischgrund T. Genetic control of the immune response in mice. IV. Relationship between graft vs host reactivity and possession of the high tumor genotypes A y a and A vy a. J Immunol. 1973 Jan;110(1):305–308. [PubMed] [Google Scholar]
  13. Gasser D. L. Genetic control of the immune response in mice. I. Segregation data and localization to the fifth linkage group of a gene affecting antibody production. J Immunol. 1969 Jul;103(1):66–70. [PubMed] [Google Scholar]
  14. Good R. A. Relations between immunity and malignancy. Proc Natl Acad Sci U S A. 1972 Apr;69(4):1026–1032. doi: 10.1073/pnas.69.4.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Good R. A., West A., Fernandes G. Nutritional modulation of immune responses. Fed Proc. 1980 Nov;39(13):3098–3104. [PubMed] [Google Scholar]
  16. HESTON W. E., VLAHAKIS G. Genetic obesity and neoplasia. J Natl Cancer Inst. 1962 Jul;29:197–209. [PubMed] [Google Scholar]
  17. Law L. W. Immunologic responsiveness and the induction of experimental neoplasms. Cancer Res. 1966 Jun;26(6):1121–1134. [PubMed] [Google Scholar]
  18. MALMGREN R. A., BENNISON B. E., McKINLEY T. W., Jr Reduced antibody titers in mice treated with carcinogenic and cancer chemotherapeutic agents. Proc Soc Exp Biol Med. 1952 Mar;79(3):484–488. doi: 10.3181/00379727-79-19419. [DOI] [PubMed] [Google Scholar]
  19. Mintz B. Genetic mosaicism in vivo: development and disease in allophenic mice. Fed Proc. 1971 May-Jun;30(3):935–943. [PubMed] [Google Scholar]
  20. Peled A., Haran-Ghera N. Immunosuppression by the radiation leukemia virus and its relation to lymphatic leukemia development. Int J Cancer. 1971 Jul 15;8(1):97–106. doi: 10.1002/ijc.2910080113. [DOI] [PubMed] [Google Scholar]
  21. Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem. 1974 Oct;20(10):1255–1270. [PubMed] [Google Scholar]
  22. Rygaard J., Povlsen C. O. Is immunological surveillance not a cell-mediated immune function? Transplantation. 1974 Jan 1;17(1):135–136. [PubMed] [Google Scholar]
  23. Shechter Y., Maron R., Elias D., Cohen I. R. Autoantibodies to insulin receptor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science. 1982 Apr 30;216(4545):542–545. doi: 10.1126/science.7041258. [DOI] [PubMed] [Google Scholar]
  24. Speirs R. S., Benson R. W., Roberts D. W. Modification of antibody response to type III pneumopolysaccharide by route of injection of pertussis vaccine. Infect Immun. 1979 Mar;23(3):675–680. doi: 10.1128/iai.23.3.675-680.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stutman O. Immunologic studies on resistance to oncogenic agents in mice. Natl Cancer Inst Monogr. 1972 Dec;35:107–115. [PubMed] [Google Scholar]
  26. Stutman O. Spontaneous tumors in nude mice: effect of the viable yellow gene. Exp Cell Biol. 1979;47(2):129–135. doi: 10.1159/000162929. [DOI] [PubMed] [Google Scholar]
  27. Vlahakis G., Heston W. E. Spontaneous cholangiomas in strain C3H-AvyfB mice and in their hybrids. J Natl Cancer Inst. 1971 Mar;46(3):677–683. [PubMed] [Google Scholar]
  28. Wolff G. L. Influence of maternal phenotype on metabolic differentiation of agouti locus mutants in the mouse. Genetics. 1978 Mar;88(3):529–539. doi: 10.1093/genetics/88.3.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wolff G. L., Kodell R. L., Cameron A. M., Medina D. Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c X VY) F1 hybrid mice. J Toxicol Environ Health. 1982 Jul;10(1):131–142. doi: 10.1080/15287398209530237. [DOI] [PubMed] [Google Scholar]
  30. Wolff G. L. Masking of mutant metabolic phenotypes by prenatal maternal influences. Prog Clin Biol Res. 1982;94:463–470. [PubMed] [Google Scholar]
  31. Wolff G. L., Medina D., Umholtz R. L. Manifestation of hyperplastic alveolar nodules and mammary tumors in "viable yellow" and non-yellow mice. J Natl Cancer Inst. 1979 Sep;63(3):781–785. doi: 10.1093/jnci/63.3.781. [DOI] [PubMed] [Google Scholar]
  32. Wolff G. L., Pitot H. C. Variation of hepatic malic enzyme capacity with hepatoma susceptibility in mice of different genotypes. Cancer Res. 1972 Sep;32(9):1861–1863. [PubMed] [Google Scholar]
  33. Yen T. T., Allan J. A., Yu P. L., Acton M. A., Pearson D. V. Triacylglycerol contents and in vivo lipogenesis of ob/ob, db/db and Avy/a mice. Biochim Biophys Acta. 1976 Aug 23;441(2):213–220. doi: 10.1016/0005-2760(76)90164-8. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES